Feedback / Questions
ETX101 - Encoded Therap
https://www.businesswire.com/news/home/20260112051311/en/Encoded-Therapeutics-Announces-U.S.-FDA-Breakthrough-Therapy-Designation-Granted-to-ETX101-for-the-Treatment-of-Dravet-Syndrome
Jan 12, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next